The tumour suppressor CYLD regulates the p53 DNA damage response
CYLD is a deubiquitinase known to act as a tumour suppressor in different models of carcinogenesis. Here, the authors show that CYLD suppresses carcinogen-induced tumorigenesis by deubiquitinating p53 and promoting its stabilization and activation in response to DNA damage.
Guardado en:
Autores principales: | Vanesa Fernández-Majada, Patrick-Simon Welz, Maria A. Ermolaeva, Michael Schell, Alexander Adam, Felix Dietlein, David Komander, Reinhard Büttner, Roman K. Thomas, Björn Schumacher, Manolis Pasparakis |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/79bd90df0bdb446e800325e92d9eaee1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Regulation of the DNA damage response and gene expression by the Dot1L histone methyltransferase and the 53Bp1 tumour suppressor.
por: Jennifer FitzGerald, et al.
Publicado: (2011) -
Rare CYLD Variants in Chinese Patients With Amyotrophic Lateral Sclerosis
por: Xiaojing Gu, et al.
Publicado: (2021) -
Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors
por: Jiqiu Cheng, et al.
Publicado: (2017) -
PEPD is a pivotal regulator of p53 tumor suppressor
por: Lu Yang, et al.
Publicado: (2017) -
Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors
por: Jiqiu Cheng, et al.
Publicado: (2019)